Real-World Data on Botensilimab Plus Balstilimab in Advanced Sarcoma at ESMO 2026 / Agenus, Balstilimab, botensilimab, cancer ...
New Knowledge, Fresh Perspectives, and Renewed Motivation From ESMO 2026 / cancer, esmo 2026, ESMO2026, ESMO26, GSK, ...
A Paradigm Shift in Oligometastatic Head and Neck Cancer / cancer, Head and Neck Cancer, Head and Neck oncology, Juliette ...
MFCR Congratulates Dan Landau on His Emerging Leader Award / European Oncology Nursing Society (EONS) ESMO - European ...
Why NGS Fails Without the Right Workflow / AI in oncology, biomarker testing, cancer, cancer genomics, Clinical Decision ...
The Ovarian Cancer Canada Breakthrough Fund 2026 supports pragmatic clinical trials advancing ovarian cancer early detection ...
Celebrating the UMKC School of Medicine’s 55th Anniversary and Reunion Weekend Gala / Alexander Norbash, Amelia Howard, Amy K ...
Who Owns the Message? Key Takeaways from OncoDaily’s Exclusive Brunch at ESMO 2026 ...
Who Owns the Message? Key Takeaways from OncoDaily’s Exclusive Brunch at ESMO 2026 ...
OptiTROP-Breast01 Final Analysis: Sacituzumab Tirumotecan Sustains Overall Survival Benefit in Previously Treated Metastatic Triple-Negative Breast Cancer ...
At the Community Oncology Global Congress (COGC 2026), organized by OncoDaily, Amol Akhade, Senior Consultant in Medical ...
SHR-A2102 at ESMO 2026 Shows 47.2% Response Rate in Recurrent or Metastatic Cervical Cancer / cancer, ESMO, esmo 2026, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results